Neogen EBITDA Margin 2010-2025 | NEOG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Neogen (NEOG) over the last 10 years. The current EBITDA margin for Neogen as of February 28, 2025 is .
| Neogen EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-02-28 | $0.91B | $0.16B | 17.66% |
| 2024-11-30 | $0.91B | $0.16B | 17.94% |
| 2024-08-31 | $0.91B | $0.17B | 18.40% |
| 2024-05-31 | $0.93B | $0.18B | 19.89% |
| 2024-02-29 | $0.93B | $0.19B | 20.65% |
| 2023-11-30 | $0.92B | $0.19B | 21.11% |
| 2023-08-31 | $0.92B | $0.17B | 18.28% |
| 2023-05-31 | $0.82B | $0.13B | 15.94% |
| 2023-02-28 | $0.72B | $0.10B | 13.89% |
| 2022-11-30 | $0.63B | $0.07B | 10.95% |
| 2022-08-31 | $0.53B | $0.07B | 12.62% |
| 2022-05-31 | $0.53B | $0.08B | 15.56% |
| 2022-02-28 | $0.51B | $0.08B | 16.34% |
| 2021-11-30 | $0.50B | $0.09B | 18.29% |
| 2021-08-31 | $0.49B | $0.10B | 20.12% |
| 2021-05-31 | $0.47B | $0.10B | 20.30% |
| 2021-02-28 | $0.45B | $0.09B | 20.89% |
| 2020-11-30 | $0.43B | $0.09B | 21.02% |
| 2020-08-31 | $0.43B | $0.09B | 21.13% |
| 2020-05-31 | $0.42B | $0.09B | 20.81% |
| 2020-02-29 | $0.42B | $0.09B | 20.29% |
| 2019-11-30 | $0.42B | $0.09B | 20.62% |
| 2019-08-31 | $0.42B | $0.09B | 20.67% |
| 2019-05-31 | $0.42B | $0.09B | 20.72% |
| 2019-02-28 | $0.41B | $0.09B | 21.07% |
| 2018-11-30 | $0.41B | $0.09B | 21.46% |
| 2018-08-31 | $0.40B | $0.09B | 21.53% |
| 2018-05-31 | $0.40B | $0.09B | 21.61% |
| 2018-02-28 | $0.39B | $0.09B | 22.02% |
| 2017-11-30 | $0.38B | $0.08B | 21.90% |
| 2017-08-31 | $0.37B | $0.08B | 21.95% |
| 2017-05-31 | $0.36B | $0.08B | 22.01% |
| 2017-02-28 | $0.35B | $0.08B | 21.25% |
| 2016-11-30 | $0.34B | $0.07B | 20.76% |
| 2016-08-31 | $0.33B | $0.07B | 20.85% |
| 2016-05-31 | $0.32B | $0.07B | 21.43% |
| 2016-02-29 | $0.31B | $0.07B | 21.54% |
| 2015-11-30 | $0.30B | $0.07B | 22.52% |
| 2015-08-31 | $0.29B | $0.07B | 22.76% |
| 2015-05-31 | $0.28B | $0.06B | 22.61% |
| 2015-02-28 | $0.27B | $0.06B | 22.51% |
| 2014-11-30 | $0.27B | $0.06B | 22.26% |
| 2014-08-31 | $0.26B | $0.06B | 21.40% |
| 2014-05-31 | $0.25B | $0.05B | 21.37% |
| 2014-02-28 | $0.24B | $0.05B | 21.52% |
| 2013-11-30 | $0.23B | $0.05B | 22.12% |
| 2013-08-31 | $0.22B | $0.05B | 23.04% |
| 2013-05-31 | $0.21B | $0.05B | 23.08% |
| 2013-02-28 | $0.20B | $0.05B | 22.89% |
| 2012-11-30 | $0.20B | $0.04B | 22.05% |
| 2012-08-31 | $0.19B | $0.04B | 21.69% |
| 2012-05-31 | $0.19B | $0.04B | 21.62% |
| 2012-02-29 | $0.18B | $0.04B | 22.22% |
| 2011-11-30 | $0.18B | $0.04B | 22.60% |
| 2011-08-31 | $0.18B | $0.04B | 23.30% |
| 2011-05-31 | $0.17B | $0.04B | 23.70% |
| 2011-02-28 | $0.17B | $0.04B | 23.21% |
| 2010-11-30 | $0.16B | $0.04B | 23.13% |
| 2010-08-31 | $0.15B | $0.03B | 22.52% |
| 2010-05-31 | $0.14B | $0.03B | 22.14% |
| 2010-02-28 | $0.13B | $0.03B | 21.97% |
| 2009-11-30 | $0.13B | $0.03B | 21.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.055B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |